We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

1 hedge funds and large institutions have $50K invested in BioCardia, Inc. Warrant in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LTFS
Ladenburg Thalmann Financial Services
Florida
+$58.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
1
Ladenburg Thalmann Financial Services
Florida
$50K +$58.8K +63,088 New

BCDAW Hedge Fund Activity: Q3 2019 in Review

1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q3 2019, worth a combined $50K.

Buyers outnumbered sellers: 1 fund opened new BCDAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Ladenburg Thalmann Financial Services, opening a new position worth an estimated $58.8K.

  • 1 institutional investor held BioCardia, Inc. Warrant (BCDAW) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $50K of BioCardia, Inc. Warrant stock for Q3 2019.
  • 1 fund opened new BioCardia, Inc. Warrant positions in Q3 2019 and 0 closed out, a net change of +1 holder.
  • The largest BioCardia, Inc. Warrant buyer in Q3 2019 was Ladenburg Thalmann Financial Services, an estimated $58.8K added.

Based on aggregated 13F filings for Q3 2019.